Select Page

SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countouriotis, M.D., will participate in question and answer sessions at the Wells Fargo Virtual Healthcare Conference on Sept. 9 and the Citi 15th Annual BioPharma Virtual Conference on Sept. 10.